Ranitidine (as HCl) 1mg/mL in sodium chloride 0.45%; IV infusion; preservative-free. History of acute porphyria: not recommended. Renal impairment: reduce dose. Hepatic dysfunction. Discontinue if ...
How do you explain one Zantac manufacturer kiboshing a favorable trend of defense verdicts and decisions – with a massive $2.2 billion settlement? The answer appears to lie with the whistleblower suit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback